Latest filing published 21 Mar 2023 for Champions Oncology, INC., €47k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 24 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +28.2%Entry US$4.15 · Close at T+365 US$5.32
- +110.6%Entry US$5.65 · Close at T+365 US$11.90
- +9.1%Entry US$7.35 · Close at T+365 US$8.02
- +169.0%Entry US$3.64 · Close at T+365 US$9.79
- +167.0%Entry US$3.64 · Close at T+365 US$9.72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ronnie Morris: trading record in brief
Ronnie Morris discloses dealings in Champions Oncology, Inc. to SEC (Form 4). The record holds 34 filings, for trades running from 28 January 2013 to 17 March 2023.
The open-market side counts 26 purchases for €596k alongside 1 sale for €366. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 4 option exercises. So far in 2023, the count stands at 1 purchase and no sales.
The median purchase comes to €8,477. Clusters matter here: 13 out of 21 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 24 purchases show a median change of +102.8%, with the price up in 88% of them. This is a record of the past, not a forecast.
The record was last updated on 21 March 2023 with an open-market purchase (€47k) in Champions Oncology, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ronnie Morris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,382 shares@ US$4.0356100.0% of flowCommon StockSEC:0001628280-23-008699:0Canonical exit: 15 Jun 2023 (T+90)
- 124,232 shares@ US$5.7691.4% of flowCommon StockSEC:0001628280-20-015394:0
- 2,708 shares@ US$4.801.7% of flowCommon StockSEC:0001628280-20-015394:1
- 75 shares@ US$5.250.1% of flowCommon StockSEC:0001628280-20-004085:0
- 75 shares@ US$4.750.0% of flowCommon StockSEC:0001628280-20-003966:0Canonical exit: 18 Jun 2020 (T+90)
- 4,167 shares@ US$4.800.4% of flowCommon StockSEC:0001628280-19-000359:0
- 20,000 shares@ US$7.443.2% of flowCommon StockSEC:0001628280-18-015324:0Canonical exit: 19 Mar 2019 (T+90)
- 303,581 shares@ US$12.3479.1% of flowCommon StockSEC:0001628280-18-012548:0
- 2,235 shares@ US$3.570.1% of flowCommon StockSEC:0001628280-18-003737:0Canonical exit: 24 Jun 2018 (T+90)
- 2,300 shares@ US$3.620.1% of flowCommon StockSEC:0001628280-18-003737:1Canonical exit: 25 Jun 2018 (T+90)
- 60 shares@ US$3.500.0% of flowCommon StockSEC:0001628280-18-003566:0Canonical exit: 20 Jun 2018 (T+90)
- 440 shares@ US$3.500.0% of flowCommon StockSEC:0001628280-18-003566:1Canonical exit: 21 Jun 2018 (T+90)
- 200 shares@ US$3.480.0% of flowCommon StockSEC:0001628280-18-003566:2Canonical exit: 20 Jun 2018 (T+90)
- 10,000 shares@ US$1.640.3% of flowCommon StockSEC:0001628280-16-020189:0Canonical exit: 19 Jan 2017 (T+90)
- 10,000 shares@ US$1.670.3% of flowCommon StockSEC:0001628280-16-020189:1Canonical exit: 19 Jan 2017 (T+90)
- 10,000 shares@ US$1.680.3% of flowCommon StockSEC:0001628280-16-020189:2Canonical exit: 19 Jan 2017 (T+90)
- 10,000 shares@ US$1.700.3% of flowCommon StockSEC:0001628280-16-020147:0Canonical exit: 17 Jan 2017 (T+90)
- 305 shares@ US$1.660.0% of flowCommon StockSEC:0001628280-16-020090:0Canonical exit: 12 Jan 2017 (T+90)
- 10,000 shares@ US$1.660.3% of flowCommon StockSEC:0001628280-16-020090:1Canonical exit: 12 Jan 2017 (T+90)
- 10,000 shares@ US$1.680.3% of flowCommon StockSEC:0001628280-16-020069:0Canonical exit: 11 Jan 2017 (T+90)
- 4,357 shares@ US$1.660.1% of flowCommon StockSEC:0001628280-16-020069:1Canonical exit: 11 Jan 2017 (T+90)
- 5,643 shares@ US$1.660.2% of flowCommon StockSEC:0001628280-16-020069:2Canonical exit: 11 Jan 2017 (T+90)
- 9,695 shares@ US$1.660.3% of flowCommon StockSEC:0001628280-16-020069:3Canonical exit: 11 Jan 2017 (T+90)
- 4,537 shares@ US$1.660.1% of flowCommon StockSEC:0001628280-16-020006:0Canonical exit: 8 Jan 2017 (T+90)
- 5,000 shares@ US$1.660.2% of flowCommon StockSEC:0001628280-16-020006:1Canonical exit: 8 Jan 2017 (T+90)
25 of 33 declarations
